ACS Applied Materials & Interfaces · 2017 · 87 citations · 51 references
PharmacyBioengineeringMaterials ScienceBiocompatibilityBiomedical ImagingNanomaterialsInorganic NanoparticlesMagnetic Resonance ImagingNanomedicineNanoparticle CharacterizationNanoparticle DesignNanoparticle FormulationsBiomedical ApplicationsContrast Agent RelaxivityDendrimer FormulationLongitudinal RelaxationLongitudinal Relaxation TimeMagnetic Resonance Imaging Contrast AgentsNanoparticle Contrast AgentsNanoparticle Imaging Agents
There has been growing interest in the research of nanomaterials for biomedical applications in recent decades. Herein, a simple approach to synthesize the G4.5-Gd 2 O 3 -poly(ethylene glycol) (G4.5-Gd 2 O 3 -PEG) nanoparticles (NPs) that demonstrate potential as dual ( T 1 and T 2 ) contrasting agents in magnetic resonance imaging (MRI) has been reported in this study. Compared to the clinically popular Gd-DTPA contrasting agents, G4.5-Gd 2 O 3 -PEG NPs exhibited a longer longitudinal relaxation time ( T 1 ) and better biocompatibility when incubated with macrophage cell line RAW264.7 in vitro . Furthermore, the longitudinal relaxivity ( r 1 ) of G4.5-Gd 2 O 3 -PEG NPs was 53.9 s –1 mM –1 at 7T, which is equivalent to 4.8 times greater than to the Gd-DTPA contrasting agents. An in vivo T 1 -weighted MRI results revealed that G4.5-Gd 2 O 3 -PEG NPs significantly enhanced signals in the intestines, kidney, liver, bladder, and spleen. In addition, the T 2 -weighted MRI results revealed darker contrast in the kidney, which proves that G4.5-Gd 2 O 3 -PEG NPs can be exploited as T 1 and T 2 contrasting agents. In summary, these findings suggest that the G4.5-Gd 2 O 3 -PEG NPs synthesized by an alternative approach can be used as dual MRI contrasting agents.
51
Ja Young Park, Myung Ju Baek, Eun Sook Choi et al. · ACS Nano · 2009 · 502 citations
Medicine, Bioengineering, Biophysics +17
Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications
Shashwat S. Banerjee, Naval D. Aher, Rajesh B. Patil et al. · Journal of Drug Delivery · 2012 · 282 citations · Full text
Pharmacy, Oncology, Pharmaceutics +17